Page last updated: 2024-09-03

phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and veratridine

phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with veratridine in 1 studies

Compound Research Comparison

Studies
(phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide)
Trials
(phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide)
Recent Studies (post-2010)
(phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide)
Studies
(veratridine)
Trials
(veratridine)
Recent Studies (post-2010) (veratridine)
2760551,755086

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castes, E; Devillers, JP; Labrouche, SA; Simonnet, G1

Other Studies

1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and veratridine

ArticleYear
Release of neuropeptide FF, an anti-opioid peptide, in rat spinal cord slices is voltage- and Ca(2+)-sensitive: possible involvement of P-type Ca2+ channels.
    Journal of neurochemistry, 1995, Volume: 64, Issue:4

    Topics: Animals; Calcium; Calcium Channels; Electrophysiology; Endorphins; In Vitro Techniques; Male; Oligopeptides; Ouabain; Perfusion; Potassium; Radioligand Assay; Rats; Rats, Wistar; Spinal Cord; Veratridine

1995